نتایج جستجو برای: pharmacogenetic

تعداد نتایج: 2484  

Journal: :QJM : monthly journal of the Association of Physicians 2010
O Jolobe

Beyond these insights there are further applications and future challenges Sir, Insights into the genetic susceptibility to Crohn's disease (CD) 1 would be incomplete without recognition that the unrivalled success of azathioprine in inducing and maintaining remission in corticoster-oid-dependent CD 2 ought to go hand in hand with a wider application of pharmacogenetic testing 3 so as to optimi...

Journal: :Pharmacological reviews 1997
W Kalow

What have we learned? Pharmacogenetics, heritable variation in response to xenobiotics, is present in all forms of life. Initially, human data perhaps have created the most excitement, and they provide much biochemical detail. However, if we look at pharmacogenetic variation of insects and bacteria, we see it as a characteristic of populations; individuals with inborn resistance to various toxi...

2015

Learning Objectives At the end of this activity, participants should be able to:  explain basic pharmacogenomic and pharmacogenetic concepts.  explain how genetic variation in proteins, including drug transporters and drug metabolizing enzymes, affect drug metabolism and drug response.  discuss the availability of evidence-based guidelines and utilize them for the selection of drug therapy. ...

2014
Iris Postmus Stella Trompet Harshal A. Deshmukh Michael R. Barnes Xiaohui Li Helen R. Warren Daniel I. Chasman Kaixin Zhou Benoit J. Arsenault Louise A. Donnelly Kerri L. Wiggins Christy L. Avery Paula Griffin QiPing Feng Kent D. Taylor Guo Li Daniel S. Evans Albert V. Smith Catherine E. de Keyser Andrew D. Johnson Anton J. M. de Craen David J. Stott Brendan M. Buckley Ian Ford Rudi G. J. Westendorp P. Eline Slagboom Naveed Sattar Patricia B. Munroe Peter Sever Neil Poulter Alice Stanton Denis C. Shields Eoin O’Brien Sue Shaw-Hawkins Y.-D. Ida Chen Deborah A. Nickerson Joshua D. Smith Marie Pierre Dubé S. Matthijs Boekholdt G. Kees Hovingh John J. P. Kastelein Paul M. McKeigue John Betteridge Andrew Neil Paul N. Durrington Alex Doney Fiona Carr Andrew Morris Mark I. McCarthy Leif Groop Emma Ahlqvist Joshua C. Bis Kenneth Rice Nicholas L. Smith Thomas Lumley Eric A. Whitsel Til Stürmer Eric Boerwinkle Julius S. Ngwa Christopher J. O’Donnell Ramachandran S. Vasan Wei-Qi Wei Russell A. Wilke Ching-Ti Liu Fangui Sun Xiuqing Guo Susan R Heckbert Wendy Post Nona Sotoodehnia Alice M. Arnold Jeanette M. Stafford Jingzhong Ding David M. Herrington Stephen B. Kritchevsky Gudny Eiriksdottir Leonore J. Launer Tamara B. Harris Audrey Y. Chu Franco Giulianini Jean G. MacFadyen Bryan J. Barratt Fredrik Nyberg Bruno H. Stricker André G. Uitterlinden Albert Hofman Fernando Rivadeneira Valur Emilsson Oscar H. Franco Paul M. Ridker Vilmundur Gudnason Yongmei Liu Joshua C. Denny Christie M. Ballantyne Jerome I. Rotter L. Adrienne Cupples Bruce M. Psaty Colin N. A. Palmer Jean-Claude Tardif Helen M. Colhoun Graham Hitman Ronald M. Krauss J Wouter Jukema Mark J. Caulfield Peter Donnelly Ines Barroso Jenefer M. Blackwell Elvira Bramon Matthew A. Brown Juan P. Casas Aiden Corvin Panos Deloukas Audrey Duncanson Janusz Jankowski Hugh S. Markus Christopher G. Mathew Colin N. A. Palmer Robert Plomin Anna Rautanen Stephen J. Sawcer Richard C. Trembath Ananth C. Viswanathan Nicholas W. Wood Chris C. A. Spencer Gavin Band Céline Bellenguez Colin Freeman Garrett Hellenthal Eleni Giannoulatou Matti Pirinen Richard Pearson Amy Strange Zhan Su Damjan Vukcevic Cordelia Langford Sarah E. Hunt Sarah Edkins Rhian Gwilliam Hannah Blackburn Suzannah J. Bumpstead Serge Dronov Matthew Gillman Emma Gray Naomi Hammond Alagurevathi Jayakumar Owen T. McCann Jennifer Liddle Simon C. Potter Radhi Ravindrarajah Michelle Ricketts Matthew Waller Paul Weston Sara Widaa Pamela Whittaker Mark I. McCarthy

Statins effectively lower LDL cholesterol levels in large studies and the observed interindividual response variability may be partially explained by genetic variation. Here we perform a pharmacogenetic meta-analysis of genome-wide association studies (GWAS) in studies addressing the LDL cholesterol response to statins, including up to 18,596 statin-treated subjects. We validate the most promis...

2003
François Alhenc-Gelas Laurent Parmentier Anne Bisagni

The topics discussed in this article are concerned with studying genomic polymorphism and identifying new therapeutic targets, the role of genetics in preclinical and clinical drug development, and cultural, regulatory and logistical aspects of the development of pharmacogenetics in France. The conclusions are that from a physiological, biochemical or genomic point of view, the study of human g...

2005
Elizabeta Topic

One of the main goals to improve chemotherapy in cancer patients is to increase the safety while not reducing the efficacy of therapy. Cancer chemotherapy is mainly empirical with the majority of cytotoxic agents given at a fixed dosage based on either body surface area or weight. These compounds have a narrow therapeutic index, and there is no simple index for monitoring pharmacological effect...

Journal: :International journal of pharmaceutical compounding 2013
Brian Fichter Tom Heintzelman Sawan Hurst Dorothy Fitzsimmons Christina Mailloux

Pharmacists must consider all factors when dosing medication for a patient. Until recently, however, one key piece to this puzzle was missing--genetics. This invisible piece of the puzzle can now be utilized with pharmacogenetic testing. By using pharmacogenetic testing, the compounding pharmacist will be able to better predict disease risk as well as the pharmacodynamic and pharmacokinetic act...

Journal: :American family physician 2007
David E Lanfear Howard L McLeod

Pharmacogenetics is a growing field of research that focuses on the interaction between genetics and drug therapy. Relationships between genetic variation and drug effect have been observed for a growing number of commonly used drugs. Validation studies may soon define the use of these relationships in clinical practice, moving the field toward routine application. Currently, there are only a f...

Journal: :The New England journal of medicine 2009
Craig B Thompson

n engl j med 360;8 nejm.org february 19, 2009 813 medicines should be an overarching goal for pharmacotherapy over the next decade. Pharmacogenetics has the potential to increase benefit and reduce harm in people whose drug responses are not “average.” In some cases, randomized, controlled trials will be needed to determine whether pharmacogenetic testing is worthwhile; in others, less rigorous...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید